286 related articles for article (PubMed ID: 20219824)
21. Proline hydroxylation and gene expression.
Kaelin WG
Annu Rev Biochem; 2005; 74():115-28. PubMed ID: 15952883
[TBL] [Abstract][Full Text] [Related]
22. Blood and bones: osteoblastic HIF signaling regulates erythropoiesis.
Wu C; Rankin EB; Giaccia AJ
Cell Cycle; 2012 Jun; 11(12):2221-2. PubMed ID: 22627672
[TBL] [Abstract][Full Text] [Related]
23. Retinoic acid regulates erythropoietin production cooperatively with hypoxia-inducible factors in human iPSC-derived erythropoietin-producing cells.
Katagiri N; Hitomi H; Mae SI; Kotaka M; Lei L; Yamamoto T; Nishiyama A; Osafune K
Sci Rep; 2021 Feb; 11(1):3936. PubMed ID: 33594180
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietin gene expression in renal carcinoma is considerably more frequent than paraneoplastic polycythemia.
Wiesener MS; Münchenhagen P; Gläser M; Sobottka BA; Knaup KX; Jozefowski K; Jürgensen JS; Roigas J; Warnecke C; Gröne HJ; Maxwell PH; Willam C; Eckardt KU
Int J Cancer; 2007 Dec; 121(11):2434-42. PubMed ID: 17640059
[TBL] [Abstract][Full Text] [Related]
25. A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia.
Frey H; Moreth K; Hsieh LT; Zeng-Brouwers J; Rathkolb B; Fuchs H; Gailus-Durner V; Iozzo RV; de Angelis MH; Schaefer L
Glycoconj J; 2017 Jun; 34(3):393-404. PubMed ID: 27600268
[TBL] [Abstract][Full Text] [Related]
26. Activation of Hypoxia Signaling in Stromal Progenitors Impairs Kidney Development.
Gerl K; Steppan D; Fuchs M; Wagner C; Willam C; Kurtz A; Kurt B
Am J Pathol; 2017 Jul; 187(7):1496-1511. PubMed ID: 28527294
[TBL] [Abstract][Full Text] [Related]
27. TP0463518, a novel inhibitor for hypoxia-inducible factor prolyl hydroxylases, increases erythropoietin in rodents and monkeys with a good pharmacokinetics-pharmacodynamics correlation.
Kato S; Takayama N; Takano H; Koretsune H; Koizumi C; Kunioka EI; Uchida S; Takahashi T; Yamamoto K
Eur J Pharmacol; 2018 Nov; 838():138-144. PubMed ID: 30179610
[TBL] [Abstract][Full Text] [Related]
28. Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia.
Ladroue C; Hoogewijs D; Gad S; Carcenac R; Storti F; Barrois M; Gimenez-Roqueplo AP; Leporrier M; Casadevall N; Hermine O; Kiladjian JJ; Baruchel A; Fakhoury F; Bressac-de Paillerets B; Feunteun J; Mazure N; Pouysségur J; Wenger RH; Richard S; Gardie B
Haematologica; 2012 Jan; 97(1):9-14. PubMed ID: 21933857
[TBL] [Abstract][Full Text] [Related]
29. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
Masson N; Ratcliffe PJ
J Cell Sci; 2003 Aug; 116(Pt 15):3041-9. PubMed ID: 12829734
[TBL] [Abstract][Full Text] [Related]
30. Congenital erythrocytosis.
Mallik N; Das R; Malhotra P; Sharma P
Eur J Haematol; 2021 Jul; 107(1):29-37. PubMed ID: 33840141
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia and the HIF system in kidney disease.
Nangaku M; Eckardt KU
J Mol Med (Berl); 2007 Dec; 85(12):1325-30. PubMed ID: 18026918
[TBL] [Abstract][Full Text] [Related]
32. Differential HIF and NOS responses to acute anemia: defining organ-specific hemoglobin thresholds for tissue hypoxia.
Tsui AK; Marsden PA; Mazer CD; Sled JG; Lee KM; Henkelman RM; Cahill LS; Zhou YQ; Chan N; Liu E; Hare GM
Am J Physiol Regul Integr Comp Physiol; 2014 Jul; 307(1):R13-25. PubMed ID: 24760996
[TBL] [Abstract][Full Text] [Related]
33. Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.
Chowdhury R; McDonough MA; Mecinović J; Loenarz C; Flashman E; Hewitson KS; Domene C; Schofield CJ
Structure; 2009 Jul; 17(7):981-9. PubMed ID: 19604478
[TBL] [Abstract][Full Text] [Related]
34. Renal Anemia Model Mouse Established by Transgenic Rescue with an Erythropoietin Gene Lacking Kidney-Specific Regulatory Elements.
Hirano I; Suzuki N; Yamazaki S; Sekine H; Minegishi N; Shimizu R; Yamamoto M
Mol Cell Biol; 2017 Feb; 37(4):. PubMed ID: 27920250
[TBL] [Abstract][Full Text] [Related]
35. Prolyl-4-hydroxylases 2 and 3 control erythropoietin production in renin-expressing cells of mouse kidneys.
Broeker KAE; Fuchs MAA; Schrankl J; Lehrmann C; Schley G; Todorov VT; Hugo C; Wagner C; Kurtz A
J Physiol; 2022 Feb; 600(3):671-694. PubMed ID: 34863041
[TBL] [Abstract][Full Text] [Related]
36. HIF stabilizers in the management of renal anemia: from bench to bedside to pediatrics.
Kular D; Macdougall IC
Pediatr Nephrol; 2019 Mar; 34(3):365-378. PubMed ID: 29569190
[TBL] [Abstract][Full Text] [Related]
37. Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia.
Ariazi JL; Duffy KJ; Adams DF; Fitch DM; Luo L; Pappalardi M; Biju M; DiFilippo EH; Shaw T; Wiggall K; Erickson-Miller C
J Pharmacol Exp Ther; 2017 Dec; 363(3):336-347. PubMed ID: 28928122
[TBL] [Abstract][Full Text] [Related]
38. Regulation of erythropoiesis by hypoxia inducible factors (HIFs).
Kirito K
Rinsho Ketsueki; 2011 Jun; 52(6):368-75. PubMed ID: 21737989
[No Abstract] [Full Text] [Related]
39. Two new mutations in the HIF2A gene associated with erythrocytosis.
Percy MJ; Chung YJ; Harrison C; Mercieca J; Hoffbrand AV; Dinardo CL; Santos PC; Fonseca GH; Gualandro SF; Pereira AC; Lappin TR; McMullin MF; Lee FS
Am J Hematol; 2012 Apr; 87(4):439-42. PubMed ID: 22367913
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of renal anemia.
Nangaku M; Eckardt KU
Semin Nephrol; 2006 Jul; 26(4):261-8. PubMed ID: 16949463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
